Alzheimer's Disease News and Research

RSS
Alzheimer's disease (AD) is an irreversible, progressive brain disease that slowly destroys memory and thinking skills and, eventually, the ability to carry out the simplest tasks of daily living. In most people with AD, symptoms first appear after age 60. AD is the most common cause of dementia among older people, but it is not a normal part of aging. Dementia refers to a decline in cognitive function that interferes with daily life and activities. AD starts in a region of the brain that affects recent memory, then gradually spreads to other parts of the brain. Although treatment can slow the progression of AD and help manage its symptoms in some people, currently there is no cure for this devastating disease.
A guide to long-term care insurance

A guide to long-term care insurance

Hearing loss may lead to microstructural differences in temporal lobe and frontal cortex

Hearing loss may lead to microstructural differences in temporal lobe and frontal cortex

Sex-specific brain immunometabolism differences may underlie increased Alzheimer's risk in women

Sex-specific brain immunometabolism differences may underlie increased Alzheimer's risk in women

First-of-its-kind study reveals a new culprit in the formation of brain hemorrhages

First-of-its-kind study reveals a new culprit in the formation of brain hemorrhages

Higher amounts of visceral abdominal fat in midlife may increase Alzheimer's disease risk

Higher amounts of visceral abdominal fat in midlife may increase Alzheimer's disease risk

What to know about assisted living

What to know about assisted living

High cholesterol in midlife linked to later-life dementia

High cholesterol in midlife linked to later-life dementia

New insights into sporadic early-onset Alzheimer's disease

New insights into sporadic early-onset Alzheimer's disease

New method unveils the "imageable genome" for medical diagnostics

New method unveils the "imageable genome" for medical diagnostics

Circadian rest-activity patterns may signal frailty risk in older adults

Circadian rest-activity patterns may signal frailty risk in older adults

Rare APOE3-R136S mutation offers protection against Alzheimer's disease pathologies in new study

Rare APOE3-R136S mutation offers protection against Alzheimer's disease pathologies in new study

Shrinkage in the brain's hippocampus area associated with cognitive decline

Shrinkage in the brain's hippocampus area associated with cognitive decline

UMass Lowell researchers study gut microbiome's connection to neurodegenerative diseases

UMass Lowell researchers study gut microbiome's connection to neurodegenerative diseases

Longitudinal study elucidates mechanisms driving progression of neurodegenerative disorders

Longitudinal study elucidates mechanisms driving progression of neurodegenerative disorders

Investigating the link between gut inflammation, aging, and Alzheimer's disease

Investigating the link between gut inflammation, aging, and Alzheimer's disease

Non-invasive device detects Alzheimer's and Parkinson's biomarkers with high accuracy

Non-invasive device detects Alzheimer's and Parkinson's biomarkers with high accuracy

"Christchurch mutation" can block detrimental effects of Alzheimer’s risk factor

"Christchurch mutation" can block detrimental effects of Alzheimer’s risk factor

Transforming brain research with AI and machine learning

Transforming brain research with AI and machine learning

Advances in understanding and detecting Alzheimer's disease

Advances in understanding and detecting Alzheimer's disease

Is there an association between atrial fibrillation onset age and incident dementia?

Is there an association between atrial fibrillation onset age and incident dementia?

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.